Helping a medtech start-up go global
ConceptoMed AS was founded in March 2012 by an entrepreneurial team comprising a medical doctor, an industrial designer and an experienced business adviser. The aim of the company is to develop and commercialise smart medtech solutions, starting with product lines relating to needle procedures (the most common of all medical procedures).
As the company always had its eye an international market, the ConceptoMed team required robust advice on patent strategy and how to build an effective and protected portfolio of worldwide IP rights which would help to enable commercialisation and further investment in the company.
Dehns was recommended to ConceptoMed through our successful work with other Norwegian start-ups and the two teams started working together in March 2012. We act beyond the traditional role of an external patent attorney and instead provide the equivalent of an in-house IP function, actively harvesting inventions throughout the product design process and advising on the best strategy to achieve international protection.
We have been embedded in ConceptoMed’s design process from day one: holding regular meetings to review the product development process, providing tailored prior art searching, advising on patentability and suggesting how to cover potential workarounds, reviewing priority applications and adding further technical information to strengthen coverage, considering competitor IP and the patent landscape.
We work directly with CEO Christian Mide and the design team at K8 Industridesign. ConceptoMed has been through several rounds of early stage investment, and we have recently accelerated patent applications through to grant and used the Patent Prosecution Highway to demonstrate the viability of the portfolio; this has had a direct and beneficial impact on the growth of the company. We have also worked closely with Christian and his team during their commercial negotiations, for example advising on the content of NDAs and commercial presentations.
Since April 2012, Dehns has drafted and filed over 80 patent applications across 12 families, as well as a number of design and trade mark registrations. Patents have so far been granted in 5 families, and applications are pending in a number of territories including UK & Europe, PCT, USA, Brazil, Argentina, Australia, China, Hong Kong, India, Singapore, Japan, Mexico, and Russia.
In 2015 ConceptoMed entered a phase of product realisation, with CE Mark approval and international distribution agreements in place for their first generation of LuerJack® syringes. The current product range includes both “slip” and “lock” syringes, protected by granted patents in Europe and the USA.
Dehns continues to work actively with Conceptomed as they develop their next generation of LuerJack products and other medical device inventions that expand their customer offering. As in any field of technology, it can be an increasing challenge to define patentable improvements over existing solutions. Dehns is therefore embedded in Conceptomed’s product development process from an early stage.